版本:
中国

BRIEF-Highbridge Capital reports 5.39 pct passive stake in Novelion Therapeutics

May 1 Highbridge Capital Management:

* Highbridge Capital Management reports 5.39 pct passive stake in Novelion Therapeutics Inc as of April 19 - SEC filing Source text: (bit.ly/2qxg3am) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐